MADISON NORTH: Open Payments
NPI 1033720941 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 33 payments from 6 companies in 2025. Trend: 2023 $243 · 2024 $588 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $220 |
| GlaxoSmithKline, LLC. | 17 | $209 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| PFIZER INC. | 3 | $66 |
| ABBVIE INC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, NURTEC ODT, QULIPTA, AIRSUPRA, UBRELVY.
Industry payments across LA — which companies pay providers there.
